Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms

abstract

  • GD and CD produced similar efficacy and toxicity profiles consistent with prior clinical experience.

publication date

  • May 5, 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1093/annonc/mdq578

PubMed ID

  • 21084429

Additional Document Info

start page

  • 1094

end page

  • 101

volume

  • 22

number

  • 5